Companies often lead discussions with product features and fail to address the priorities driving hospital decision-making.
The Numbers
Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes.
Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.
Orthoflash®
Miach Orthopaedics initiated the Bridge Registry to assess real-world outcomes for the Bridge-Enhanced ACL Restoration (BEAR) Implant.
July 8, 2026
,
Sourced from bovine achilles tendon, the Type 1 collagen used in the wound dressing leverages robust biological properties that support tissue regeneration and repair.
July 8, 2026
,
Newton converts soft tissue dynamics into actionable intraoperative guidance, supporting more consistent and reproducible surgical execution.
July 8, 2026
,
The U.S. Phase III trial expands the investigation of umbilical cord therapy for symptomatic cartilage defects due to knee OA.
July 8, 2026
,
The platform is designed to address the operational barriers that may limit minimally invasive spine surgery.
July 6, 2026
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
